Breast Cancer

Papers
(The H4-Index of Breast Cancer is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Adipose-derived stem cells enhance the tumorigenic potential of pre-malignant breast epithelial cells through paracrine activation of PI3K–AKT pathway123
Validation of late recurrence prediction by gene expression profiles and clinicopathological factors in estrogen receptor-positive breast cancer48
Deciphering the nexus between the tumor immune microenvironment and DNA methylation in subgrouping estrogen receptor-positive breast cancer40
Exploration of treatment strategies and susceptibility gene of postoperative nausea and vomiting in breast cancer patients: a randomised controlled trial34
Quality of life and satisfaction of patients after oncoplastic or traditional breast-conserving surgery using the BREAST-Q (BCT module): a prospective study32
CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients31
Long-term local control and cosmesis of perioperative interstitial brachytherapy for partial breast irradiation following breast-conserving surgery29
A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy27
Impact of breast size and composition on the accuracy of mammography and ultrasonography in breast cancer screening26
Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a mu26
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition24
Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer23
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers22
Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors20
Clinical outcomes after post-operative radiotherapy for breast cancer patients presenting with ipsilateral supraclavicular metastasis: considerations on the cranial border of irradiation field20
Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?20
Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA20
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer19
An insight into the role of innate immune cells in breast tumor microenvironment19
0.088014125823975